期刊文献+

内镜下治疗胃息肉的疗效观察 被引量:18

Observation on the treatment effect of endoscopy for patients with gastric polyps
下载PDF
导出
摘要 目的对临床胃息肉患者治疗效果进行分析,探讨内镜下治疗胃息肉的疗效及安全性。方法对138例胃息肉患者,共197例息肉的位置、形态、大小、病理情况、治疗方式以及治疗后的复发情况、并发症发生情况进行分析。结果 197例息肉分布的部位以胃体、胃窦为主,分别占27.41%和31.98%;息肉的形态主要为隆起无蒂形(40.10%);息肉的大小以0.5~1.0cm的为主,占59.39%;病理类型主要为增生型和炎性,分别占40.10%和43.65%。197例息肉中,23例息肉行内镜下粘膜切除术,89例息肉行氩离子凝固术,46例行内镜下圈套电凝电切,39例息肉行电凝烧灼。本次调查的138例患者治疗后半年随访,两例出现复发,复发率为1.45%。结论内镜下治疗胃息肉可以起到较好的效果,具有复发率低、并发症发生率低的优点。 Objective To analyze the treatment effect of endoscopy for patients with gastric polyps, and explore the effi- cacy and safety of endoscopic in treatment of gastric polyps. Methods 197 gastric polyps were found among 138 patients, and the location, morphology, size, pathological type, treatment methods and recurrence of patients as well as complication were analyzed. Results The location of gastric polyps were in body of stomach and sinuses ventriculi, and accounted for 27. 41% and 31.98%, respectively. The main morphology was uplift sessile form (40. 10% ). The size of gastric polyps was at the range of 0. 5 - 1. 0 cm, accounted for 59. 39%. The main pathological type was hypex:plasia and inflammatory type, and accounted for 40. 10% and 43. 65%, respectively. Among 197 gastric polyps, 23 cases received EMR, 89 cases received APC, 46 cases received endoscopic a trap of electric power cut, and 39 cases received electricity burning. 138 patients were followed up half a years later, and 2 pa- tients occurred recurrence, and the recurrence rate was 1.45%. Conclusion The endoscopy in treatment of patients with gastric polyps has good effect, and has the aspects of low recurrence and complication.
出处 《四川医学》 CAS 2012年第8期1411-1413,共3页 Sichuan Medical Journal
关键词 胃息肉 胃镜 疗效 gastric polyps endoscopy efficacy
  • 相关文献

参考文献5

二级参考文献32

  • 1朱元民,刘玉兰,张艳.胃黏膜脱垂与慢性胃炎关系探讨[J].胃肠病学和肝病学杂志,2005,14(2):178-180. 被引量:21
  • 2郑青,潘嬿,张林,萧树东.评估以雷贝拉唑为基础的三联和四联方案根除幽门螺杆菌的疗效[J].胃肠病学,2006,11(11):645-647. 被引量:14
  • 3Malfertheiner P, Megraud F, O'Morain C, et al;European Helicobacter pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection -- the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther, 2002, 16 (2): 167-180.
  • 4Gomollon F, Ducons JA, Ferrero M, et al. Quadruple therapy is effective for eradicating Helicobaeter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases. Helicobacter, 1999, 4 (4): 222-225.
  • 5Gisbert JP, Boixeda D, Bermejo F, et al. Re-treatment after Helicobacter pylori eradication failure. Eur J Gastroenterol Hepatol, 1999, 11 (9): 1049-1054.
  • 6Gisbert JP, Khorrami S, Calvet X, et al. Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol, 2004, 16 (1): 89-99.
  • 7Choi HS, Park DI, Hwang S J, et al. Double-dose, new- generation proton pump inhibitors do not improve Helicobacter pylori eradication rate. Helicobacter, 2007, 12 (6): 638-642.
  • 8Villoria A, Garcia P, Calvet X, et al. Meta-analysis: high- dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther, 2008, 28 (7): 868-877.
  • 9Goodwin CS, Marshall B J, Blincow ED, et al. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol, 1988, 41 (2): 207-210.
  • 10Romano M, Cuomo A. Eradication of Helicobacter pylori: a clinical update. MedGenMed, 2004, 6 (1): 19.

共引文献83

同被引文献122

引证文献18

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部